rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Sarbani Chaudhuri

Officer

Company insider

Files Form 4 as: Officer, Rocket Pharmaceuticals.

In numbers

Trades disclosed
8
Buys
0
Sells
2
Bought
$0
Sold
$168K
Companies
1
Companies where not an officer
0
First trade
11 Feb 2026
Last trade
11 Aug 2026
Last filed
13 Aug 2026

Companies traded

Where they are an officer
RCKT Rocket PharmaceuticalsOfficer · Biotechnology · last 11 Aug 20260 buys · 2 sells

Activity over time

1 May – 1 Oct
10May 26Jun 26Aug 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 Aug 2026filed 13 Aug 2026RCKT Rocket PharmaceuticalsBiotechnologySEC FORM 4 Sold$16K4,701 at $3.50filing
11 Aug 2026filed 13 Aug 2026RCKT Rocket PharmaceuticalsBiotechnologySEC FORM 4 Sold$16K4,701 at $3.50filing
7 May 2026filed 11 May 2026RCKT Rocket PharmaceuticalsBiotechnologySEC FORM 4 Sold$68K17,650 at $3.84filing
7 May 2026filed 11 May 2026RCKT Rocket PharmaceuticalsBiotechnologySEC FORM 4 Sold$68K17,650 at $3.84filing
11 Feb 2026filed 13 Feb 2026RCKT Rocket PharmaceuticalsBiotechnologySEC FORM 4 Code A—125,924 at $0.00filing
11 Feb 2026filed 13 Feb 2026RCKT Rocket Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—189,076 at $0.00filing
11 Feb 2026filed 13 Feb 2026RCKT Rocket Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—189,076 at $0.00filing
11 Feb 2026filed 13 Feb 2026RCKT Rocket PharmaceuticalsBiotechnologySEC FORM 4 Code A—125,924 at $0.00filing

News

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Crosses Below Fifty Day Moving Average – Should You Sell?RCKT · dailypolitical.com · 22 Oct 2026

0 headlines in the last 90 days name Sarbani Chaudhuri; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Martin WilsonGeneral Counsel · General Counsel at Rocket Pharmaceuticals, filing Form 4 there in the last year
Gaurav ShahCEO · CEO at Rocket Pharmaceuticals, filing Form 4 there in the last year
Christopher James StevensChief Operating Officer · Chief Operating Officer at Rocket Pharmaceuticals, filing Form 4 there in the last year
David P. SouthwellDirector · Director at Rocket Pharmaceuticals, filing Form 4 there in the last year
Fady Ibraham MalikEVP Research & Development · Director at Rocket Pharmaceuticals, filing Form 4 there in the last year